Makaiová I, Balazovjech I, Hasík E, Synak R, Tomek D
Bratisl Lek Listy. 1989 Sep;90(9):631-6.
The authors present their first experiences with scintigraphic examination of pheochromocytoma by means of 131I-metaiodobenzylguanidine (MIBG). In two of the eight patients examined, the already established diagnosis of pheochromocytoma and paraganglioma was confirmed, in two the examination yielded confirmation of the presumed diagnosis, and in the remaining four patients presence of the tumor was excluded. In conformity with literary data, the authors found the given examination to be suitable for: 1. confirming the diagnosis of pheochromocytoma in cases with unequivocal CT findings, 2. excluding extraadrenal activity, 3. detecting relapses or the occurrence of an extraadrenal tumor, 4. detecting not suspect manifold endocrine neoplasias, 5. establishing the diagnosis of malignant pheochromocytoma, and 6. for examining patients presenting with a family history of pheochromocytoma.
作者介绍了他们首次使用131I-间碘苄胍（MIBG）对嗜铬细胞瘤进行闪烁扫描检查的经验。在接受检查的8例患者中，2例已确诊的嗜铬细胞瘤和副神经节瘤得到了证实，2例检查结果证实了推测的诊断，其余4例排除了肿瘤存在。与文献数据一致，作者发现该检查适用于：1. 在CT检查结果明确的情况下确诊嗜铬细胞瘤；2. 排除肾上腺外活性；3. 检测复发或肾上腺外肿瘤的发生；4. 检测未怀疑的多内分泌腺瘤病；5. 确诊恶性嗜铬细胞瘤；6. 用于检查有嗜铬细胞瘤家族史的患者。
